On the way towards the Sustainable Development Goal (SDG) for health, Europe has one important battle to take on: reducing the proportion of those living with undiagnosed HIV and viral hepatitis. Current status in the EU/EEA: one in seven people living with HIV are unaware of their infection, up to four out of 5 people living with hepatitis B and three out of four people with hepatitis C infection have not yet been diagnosed.
The fifth meeting of the Hepatitis B and C Network aims to bring together experts from across the EU to discuss how Europe can improve its response to the epidemics of hepatitis B and C with a focus on surveillance, estimating prevalence, and the monitoring of response.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 14-24 August 2019 and includes updates on Ebola virus disease in the Democratic Republic of the Congo, monitoring environmental sustainability of Vibrio growth in the Baltic Sea, West Nile virus infection, haemorrhagic fever with renal syndrome in Croatia and Slovenia, the mass gathering of the Hajj in Saudi Arabia and Listeriosis in Spain. (Erratum (26 August 2019): On pages 2 and 5 (West Nile virus infection), the figure of eight deaths in Greece (4), Cyprus (1) and Serbia (1) has been amended to four deaths in Greece (2), Cyprus (1) and Serbia (1)
Targeted testing is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area. Some preliminary monitoring results on the response to hepatitis B and C presented around World Hepatitis Day show that diagnosing chronic infections is still a challenge in the EU/EEA.